157 related articles for article (PubMed ID: 29572792)
1. Development of the Histoculture Drug Response Assay (HDRA).
Hoffman RM; Vescio RA
Methods Mol Biol; 2018; 1760():39-48. PubMed ID: 29572792
[TBL] [Abstract][Full Text] [Related]
2. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.
Hoffman RM
Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794
[TBL] [Abstract][Full Text] [Related]
3. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.
Hoffman RM
Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796
[TBL] [Abstract][Full Text] [Related]
4. Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.
Hoffman RM; Tanino H
Methods Mol Biol; 2018; 1760():93-100. PubMed ID: 29572797
[TBL] [Abstract][Full Text] [Related]
5. Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer.
Hoffman RM; Jung PS; Kim MB; Nam JH
Methods Mol Biol; 2018; 1760():73-81. PubMed ID: 29572795
[TBL] [Abstract][Full Text] [Related]
6. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.
Vescio RA; Redfern CH; Nelson TJ; Ugoretz S; Stern PH; Hoffman RM
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5029-33. PubMed ID: 3474637
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of the Histoculture Drug Response Assay for Prostate Cancer and Benign Prostate Hypertrophy (BPH).
Hoffman RM
Methods Mol Biol; 2018; 1760():101-107. PubMed ID: 29572798
[TBL] [Abstract][Full Text] [Related]
9. Independence of cytotoxic drug sensitivity profiles and receptor subtype of invasive ductal breast carcinoma demonstrated by the histoculture drug response assay (HDRA).
Kim KY; Chung BW; Yang I; Kim MB; Hoffman RM
Anticancer Res; 2014 Dec; 34(12):7197-201. PubMed ID: 25503149
[TBL] [Abstract][Full Text] [Related]
10. In Vivo-Like Cell-Cycle Phase Distribution of Cancer Cells in Gelfoam
Hoffman RM; Yano S
Methods Mol Biol; 2018; 1760():109-123. PubMed ID: 29572799
[TBL] [Abstract][Full Text] [Related]
11. Expression and Targeting of Tumor Markers in Gelfoam
Hoffman RM; Guadagni F
Methods Mol Biol; 2018; 1760():29-37. PubMed ID: 29572791
[TBL] [Abstract][Full Text] [Related]
12. Histoculture drug response assay to monitor chemoresponse.
Ohie S; Udagawa Y; Aoki D; Nozawa S
Methods Mol Med; 2005; 110():79-86. PubMed ID: 15901929
[TBL] [Abstract][Full Text] [Related]
13. 3D Sponge-Matrix Histoculture: An Overview.
Hoffman RM
Methods Mol Biol; 2018; 1760():11-17. PubMed ID: 29572789
[TBL] [Abstract][Full Text] [Related]
14. Imaging the Governing Step of Metastasis in Gelfoam
Hoffman RM; Chishima T
Methods Mol Biol; 2018; 1760():215-220. PubMed ID: 29572807
[TBL] [Abstract][Full Text] [Related]
15. Study on chemosensitivity of oral squamous cell carcinomas by histoculture drug response assay.
Ariyoshi Y; Shimahara M; Tanigawa N
Oral Oncol; 2003 Oct; 39(7):701-7. PubMed ID: 12907210
[TBL] [Abstract][Full Text] [Related]
16. Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.
Nakamura J; Imai E; Yoshihama M; Sasano H; Kubota T
Anticancer Res; 1998; 18(1A):125-8. PubMed ID: 9568066
[TBL] [Abstract][Full Text] [Related]
17. The measurement of glucose consumption in histoculture to determine effects of doxorubicin and cisplatinum on human gastric carcinoma.
Chang SG; Chai SE; Kim ES; Yoon C; Joo HZ; Hoffman RM
Anticancer Res; 1993; 13(5A):1303-10. PubMed ID: 8239500
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
20. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
